Elizabeth Manning Duus

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

Jennifer S. Temel, Amy P. Abernethy, David C. Currow et al. · The Lancet Oncology · 2016 · 607 citations

Romana 2, Romana 1, Non-small-cell Lung Cancer +8

Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials

José M. Garcia, Ralph V. Boccia, Charles D. Graham et al. · The Lancet Oncology · 2014 · 210 citations

Integrated Analysis, Cancer Cachexia, Medicine +11

Anamorelin HCl (ONO‐7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia‐cachexia syndrome: preclinical profile

Claudio Pietra, Yasuhiro Takeda, Naoko Tazawa-Ogata et al. · Journal of Cachexia Sarcopenia and Muscle · 2014 · 110 citations · Full text

A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF–Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer

Gang Chen, Richa Gupta, S. Petrik et al. · Cancer Immunology Research · 2014 · 90 citations · Full text

Breast Oncology, Immunology, Immunotherapeutics +18

Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model

Robert S. Northrup, Ken Kuroda, Elizabeth Manning Duus et al. · Supportive Care in Cancer · 2013 · 51 citations · Full text